Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 12, 2019

SELL
$65.7 - $83.98 $22,206 - $28,385
-338 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $20,056 - $23,605
-260 Reduced 43.48%
338 $27,000
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $46,554 - $57,413
598 New
598 $55,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Prw Wealth Management LLC Portfolio

Follow Prw Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prw Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prw Wealth Management LLC with notifications on news.